RxDoctor Payments Data

Carlos Torre, MD

Otolaryngology · Pembroke Pines, FLNPI 1053542936

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $22,850 of the $28,440 with a category attached, or 80.3%. Lilly USA, LLC accounts for 80.9% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $23,904, more than ten times the $399 reported in 2019. Among otolaryngology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$28,440in general payments, 2019–2025

Across 125 payments — averaging $227.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$23K
  • Inspire Medical Systems, Inc.$2K
  • Stryker$1K
  • Harmony Biosciences LLC$494
  • Medtronic$419
  • GSK$264
  • plus $1K from 17 others
$16,000in research payments, 2019–2025

Across 2 payments — averaging $8000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Livanova USA, Inc.$16K

What the payments were for

  • Speaking & faculty fees$22,85080%
  • Travel & lodging$7333%
  • Food & beverage$4,79017%
  • Education$550%
  • Gifts$120%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,440 in reported general payments places this provider in the 95th percentile of 586 otolaryngology providers in Florida.

See all otolaryngology providers in Florida

Medicare billing

Part B allowed, 2024
$146,565
Medicare patients
185
Services billed
2,466

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluocinolone Acetonide Oil148$5,996
Fluticasone Propionate478$4,839
Azelastine Hcl358$3,666
Pantoprazole Sodium118$1,043
Ipratropium Bromide36$989
Cephalexin15$543
Mirtazapine13$333
Zolpidem Tartrate ErZolpidem Tartrate11$285
Methylprednisolone40$243
Mupirocin39$174
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim26$171
Zolpidem Tartrate17$133
Famotidine50$132
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$115
Meclizine Hcl13$57

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Pembroke Pines

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →